Literature DB >> 14723832

Primary Intestinal Lymphangiectasia.

Charles M. Bliss1, Paul C. Schroy III.   

Abstract

A high-protein, low-fat diet supplemented with medium chain triglycerides (MCT) is the simplest, most effective, and most widely prescribed treatment with the fewest side effects. Octreotide has been helpful in cases in which treatment with MCT has failed, but it is costly and requires parenteral administration. Antiplasmin therapy may have some role when evidence of increased fibrinolysis is present. Surgery is reserved for palliation of large ascites or resection of isolated lesions.

Entities:  

Year:  2004        PMID: 14723832     DOI: 10.1007/s11938-004-0019-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  13 in total

1.  Primary intestinal lymphangiectasia: a rare disease in the differential diagnosis of acute abdomen.

Authors:  S Uğuralp; M Mutus; O Kutlu; S Cetin; T Baysal; B Mizrak
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-10       Impact factor: 2.839

Review 2.  Octreotide in pediatric patients.

Authors:  Janice B Heikenen; John F Pohl; Steven L Werlin; John C Bucuvalas
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-11       Impact factor: 2.839

3.  Operative ascitic drainage in a patient with primary intestinal lymphangiectasia.

Authors:  S M White
Journal:  Anaesthesia       Date:  2003-04       Impact factor: 6.955

4.  Intestinal lymphagiectasia: a reappraisal.

Authors:  P A Vardy; E Lebenthal; H Shwachman
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

5.  Intestinal lymphangiectasia: lack of efficacy of antiplasmin therapy?

Authors:  K Mine
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

6.  Intestinal lymphangiectasia and protein losing enteropathy responding to small bowel restriction.

Authors:  M Persić; N L Browse; I Prpić
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

7.  Intestinal lymphangiectasia markedly improved with antiplasmin therapy.

Authors:  K Mine; S Matsubayashi; Y Nakai; T Nakagawa
Journal:  Gastroenterology       Date:  1989-06       Impact factor: 22.682

8.  Octreotide for protein-losing enteropathy with intestinal lymphangiectasia.

Authors:  D J Bac; P M Van Hagen; P T Postema; A M ten Bokum; P E Zondervan; M van Blankenstein
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

9.  Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy.

Authors:  Joanna E MacLean; Eyal Cohen; Michael Weinstein
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

10.  Intestinal lymphangiectasia. Long-term results with MCT diet.

Authors:  W L Tift; J K Lloyd
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

View more
  1 in total

1.  A Clinical Approach to a Child with Hypoalbuminemia and Lymphopenia.

Authors:  Ayse Sevgi Köstel-Bal; Suna Kaymak; Şule Haskoloğlu; Zarife Kuloğlu; Arzu Ensari; Figen Doğu; Aydan Kansu; Aydan İkincioğulları
Journal:  J Clin Immunol       Date:  2016-03-30       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.